Tandem Diabetes Care (TNDM) Change in Receivables (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Change in Receivables came in at -$22.7 million in Q1 2026, down 309.17% YoY from $10.8 million in Q1 2025, and down 153.98% on a QoQ basis from $42.0 million in Q4 2025.
Tandem Diabetes Care (TNDM) Change in Receivables (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Change in Receivables data on file, last reported at -$22.7 million in Q1 2026.
- Quarterly Change in Receivables fell 309.17% year-over-year to -$22.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.3 million (down 43.75% YoY) and the FY2025 annual result came in at $56.8 million, up 173.2% from the prior year.
- Change in Receivables declined to -$22.7 million in Q1 2026, from $42.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $42.0 million in Q4 2025 to a low of -$22.8 million in Q1 2023.
- A 5-year average of $3.4 million and a median of $5.6 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2025 — Change in Receivables soared 247.71% — and 2026, when it plunged 309.17%.
- Tracing TNDM's Change in Receivables over 5 years: stood at $3.0 million in 2022, then surged by 84.41% to $5.6 million in 2023, then soared by 115.96% to $12.1 million in 2024, then soared by 247.71% to $42.0 million in 2025, then slumped by 153.98% to -$22.7 million in 2026.
- The last three Change in Receivables figures came in at -$22.7 million (Q1 2026), $42.0 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 25.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.76 Mn |
| Jun 30, 2026 | 25.76 Mn |
| Mar 31, 2026 | -22.68 Mn |
| Mar 31, 2026 | -22.68 Mn |
| Dec 31, 2025 | 42.01 Mn |
| Dec 31, 2025 | 42.01 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 10.84 Mn |
| Mar 31, 2025 | 10.84 Mn |
| Dec 31, 2024 | 12.08 Mn |
| Dec 31, 2024 | 12.08 Mn |
| Sep 30, 2024 | 11.57 Mn |
| Sep 30, 2024 | 11.57 Mn |
| Jun 30, 2024 | 6.90 Mn |
| Jun 30, 2024 | 6.90 Mn |
| Mar 31, 2024 | -9.77 Mn |
| Mar 31, 2024 | -9.77 Mn |